Allurion Technologies (ALUR) FCF Margin (2022 - 2026)
Allurion Technologies (ALUR) posted FCF Margin of 109.3% for Q1 2026, up 25.77% on a QoQ basis from 147.25% in Q4 2025, and up 6040.0% year-over-year from 1.78% in Q1 2025.
Allurion Technologies (ALUR) FCF Margin (2022 - 2026) Analysis & Trends
Allurion Technologies' FCF Margin history runs 5 years deep, the most recent figure standing at 109.3% for Q1 2026.
- Quarterly FCF Margin rose 6040.0% year-over-year to 109.3% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 180.19% (down 2588.0% YoY) and the FY2025 annual result came in at 190.06%, down 5642.0% from the prior year.
- FCF Margin was 109.3% for Q1 2026 at Allurion Technologies, up from 147.25% in the prior quarter.
- Across five years, FCF Margin topped out at 62.06% in Q3 2022 and bottomed at 270.02% in Q4 2023.
- A 5-year average of 148.04% and a median of 127.41% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin tumbled 18555 bps — and 2025, when it jumped 9017 bps.
- Allurion Technologies' FCF Margin stood at 84.47% in 2022, then plunged by 220 bps to 270.02% in 2023, then advanced by 12 bps to 237.42% in 2024, then surged by 38 bps to 147.25% in 2025, then climbed by 26 bps to 109.3% in 2026.
- Business Quant data shows ALUR's FCF Margin at 109.3% in Q1 2026, 147.25% in Q4 2025, and 245.52% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -109.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109.30% |
| Dec 31, 2025 | -147.25% |
| Sep 30, 2025 | -245.52% |
| Jun 30, 2025 | -225.84% |
| Mar 31, 2025 | -169.70% |
| Dec 31, 2024 | -237.42% |
| Sep 30, 2024 | -223.70% |
| Jun 30, 2024 | -75.87% |
| Mar 31, 2024 | -92.73% |
| Dec 31, 2023 | -270.02% |
| Sep 30, 2023 | -127.41% |
| Jun 30, 2023 | -74.11% |
| Mar 31, 2023 | -75.17% |
| Dec 31, 2022 | -84.47% |
| Sep 30, 2022 | -62.06% |